Matches in SemOpenAlex for { <https://semopenalex.org/work/W6237436> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W6237436 endingPage "73" @default.
- W6237436 startingPage "263" @default.
- W6237436 abstract "Bone remodeling is the process by which the adult skeleton is continually renewed through the highly coordinated activity of three types of cells - osteoclasts, osteoblasts, and osteocytes. Disruptions in signaling among these cells and alterations in their activity have been associated with skeletal diseases. In a rare accident of nature, some families have been found to have dense and strong bones due to a recessive loss of function mutation in the SOST gene that encodes for sclerostin, a protein expressed by osteocytes that downregulates osteoblastic bone formation. Individuals who are homozygous for this mutation have sclerosteosis, a disease with no detectable circulating sclerostin, resulting in generalized osteosclerosis with skeletal deformities, cranial nerve compression, and increased intracranial pressure due to boney overgrowth in the skull, and premature death. However, family members who are heterozygous carriers for the mutation have normal phenotype and normal lifespan, with dense bones and low risk of fracture. This observation has led to the concept that compounds that reduce sclerostin levels might mimic the heterozygous carrier state and be effective in the treatment of osteoporosis. To this end, monoclonal antibodies to sclerostin have been developed. Preclinical and early clinical studies of sclerostin inhibitors have shown robust stimulation of osteoblastic bone formation. The investigational compound that has advanced the furthest in development is AMG 785 (CDP7851), a humanized monoclonal antibody to sclerostin. Monoclonal antibodies to sclerostin represent a class of compounds with potential benefit in the treatment of osteoporosis and other skeletal disorders." @default.
- W6237436 created "2016-06-24" @default.
- W6237436 creator A5087096490 @default.
- W6237436 date "2011-10-01" @default.
- W6237436 modified "2023-10-17" @default.
- W6237436 title "Sclerostin: a novel target for intervention in the treatment of osteoporosis." @default.
- W6237436 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22031665" @default.
- W6237436 hasPublicationYear "2011" @default.
- W6237436 type Work @default.
- W6237436 sameAs 6237436 @default.
- W6237436 citedByCount "21" @default.
- W6237436 countsByYear W62374362013 @default.
- W6237436 countsByYear W62374362014 @default.
- W6237436 countsByYear W62374362015 @default.
- W6237436 countsByYear W62374362016 @default.
- W6237436 countsByYear W62374362017 @default.
- W6237436 countsByYear W62374362021 @default.
- W6237436 countsByYear W62374362022 @default.
- W6237436 crossrefType "journal-article" @default.
- W6237436 hasAuthorship W6237436A5087096490 @default.
- W6237436 hasConcept C104317684 @default.
- W6237436 hasConcept C126322002 @default.
- W6237436 hasConcept C134018914 @default.
- W6237436 hasConcept C137620995 @default.
- W6237436 hasConcept C142724271 @default.
- W6237436 hasConcept C170033053 @default.
- W6237436 hasConcept C2776541429 @default.
- W6237436 hasConcept C2777479973 @default.
- W6237436 hasConcept C2779277721 @default.
- W6237436 hasConcept C31507581 @default.
- W6237436 hasConcept C501734568 @default.
- W6237436 hasConcept C54355233 @default.
- W6237436 hasConcept C62478195 @default.
- W6237436 hasConcept C71924100 @default.
- W6237436 hasConcept C86803240 @default.
- W6237436 hasConcept C95444343 @default.
- W6237436 hasConceptScore W6237436C104317684 @default.
- W6237436 hasConceptScore W6237436C126322002 @default.
- W6237436 hasConceptScore W6237436C134018914 @default.
- W6237436 hasConceptScore W6237436C137620995 @default.
- W6237436 hasConceptScore W6237436C142724271 @default.
- W6237436 hasConceptScore W6237436C170033053 @default.
- W6237436 hasConceptScore W6237436C2776541429 @default.
- W6237436 hasConceptScore W6237436C2777479973 @default.
- W6237436 hasConceptScore W6237436C2779277721 @default.
- W6237436 hasConceptScore W6237436C31507581 @default.
- W6237436 hasConceptScore W6237436C501734568 @default.
- W6237436 hasConceptScore W6237436C54355233 @default.
- W6237436 hasConceptScore W6237436C62478195 @default.
- W6237436 hasConceptScore W6237436C71924100 @default.
- W6237436 hasConceptScore W6237436C86803240 @default.
- W6237436 hasConceptScore W6237436C95444343 @default.
- W6237436 hasIssue "65" @default.
- W6237436 hasLocation W62374361 @default.
- W6237436 hasOpenAccess W6237436 @default.
- W6237436 hasPrimaryLocation W62374361 @default.
- W6237436 hasRelatedWork W1884609619 @default.
- W6237436 hasRelatedWork W1970730570 @default.
- W6237436 hasRelatedWork W1975979596 @default.
- W6237436 hasRelatedWork W2022695623 @default.
- W6237436 hasRelatedWork W2041938128 @default.
- W6237436 hasRelatedWork W2091140190 @default.
- W6237436 hasRelatedWork W2095622015 @default.
- W6237436 hasRelatedWork W2105853087 @default.
- W6237436 hasRelatedWork W2128714854 @default.
- W6237436 hasRelatedWork W2160818938 @default.
- W6237436 hasVolume "12" @default.
- W6237436 isParatext "false" @default.
- W6237436 isRetracted "false" @default.
- W6237436 magId "6237436" @default.
- W6237436 workType "article" @default.